Hot Life Science Investor Mandate 1: Corporate VC Seeks Series A-B Deals In Cardiac Devices & Neuromodulation

4 Feb

A global medical technology company based in London, UK focuses on cardiovascular and neuromodulation technologies. The firm typically invests early on in the development (series A or B) stage. The firm seeks to invest in the range of $1M-$15M per company, though would pursue larger ($100M and up) deals if there were a strong rationale that would make the company an ideal, revenue-generating fit to the portfolio. The firm currently manages a growing fund, and seeks to make 1-2 larger deals and 3-4 smaller ones within the next year. The firm seeks investments globally, and has a specific focus on USA and European-based companies.

Sectors & Subsectors of Interest: 

The firm focuses on medical devices in the cardiovascular space (cardiovascular disease and associated comorbidity such as sleep apnea, etc.), specifically in technology for invasive procedures and neuromodulation areas such as stimulation for heart failure. In the cardiovascular space, the firm has interest in cardiac surgery technology, such as minimally invasive valves, tissue valves, mechanical heart valves, open-heart valves, blood circulation and transfusion technology, and blood management systems, among others. The firm is also interested in cardiac rhythmic management, such as remote monitoring technology, electro and neurostimulation, software technology, and pacemakers.

The firm will look at companies in the clinical, close to end of development stage that may be in its final round of fundraising for clinical trials. The firm is not currently focused on therapeutics or lab equipment technology, though may be open to those used to assist procedures in the cardiovascular/neurostimulation space. The firm looks at both PMA and 510K devices, as it traditionally invests in PMA devices, and is now gaining an increasing interest in 510K devices.

The firm prefers experienced management teams, and may take a board or observer seat after an investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: